These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

165 related items for PubMed ID: 23035072

  • 21. Fingolimod in active multiple sclerosis: an impressive decrease in Gd-enhancing lesions.
    Muris AH, Rolf L, Damoiseaux J, Koeman E, Hupperts R.
    BMC Neurol; 2014 Aug 20; 14():164. PubMed ID: 25138918
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Fingolimod-induced atrioventricular conduction defects in a young lady with multiple sclerosis--insights into possible drug mechanism.
    Voon V, Saiva L, O'Kelly S, Keane D.
    Eur J Clin Pharmacol; 2014 Mar 20; 70(3):373-5. PubMed ID: 24309839
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Fingolimod for multiple sclerosis: mechanism of action, clinical outcomes, and future directions.
    Mehling M, Kappos L, Derfuss T.
    Curr Neurol Neurosci Rep; 2011 Oct 20; 11(5):492-7. PubMed ID: 21789537
    [Abstract] [Full Text] [Related]

  • 28. Fingolimod versus intramuscular interferon in patient subgroups from TRANSFORMS.
    Cohen JA, Barkhof F, Comi G, Izquierdo G, Khatri B, Montalban X, Pelletier J, Eckert B, Häring DA, Francis G.
    J Neurol; 2013 Aug 20; 260(8):2023-32. PubMed ID: 23632946
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Severe disease reactivation in four patients with relapsing-remitting multiple sclerosis after fingolimod cessation.
    Berger B, Baumgartner A, Rauer S, Mader I, Luetzen N, Farenkopf U, Stich O.
    J Neuroimmunol; 2015 May 15; 282():118-22. PubMed ID: 25903738
    [Abstract] [Full Text] [Related]

  • 33. FTY720: a most promising immunosuppressant modulating immune cell functions.
    Zhang Z, Schluesener HJ.
    Mini Rev Med Chem; 2007 Aug 15; 7(8):845-50. PubMed ID: 17692046
    [Abstract] [Full Text] [Related]

  • 34. Multiple sclerosis: Cladribine--a contentious therapeutic contender for MS.
    Hohlfeld R.
    Nat Rev Neurol; 2011 Jul 12; 7(8):425-7. PubMed ID: 21750524
    [No Abstract] [Full Text] [Related]

  • 35. FTY: not just a homely drug.
    Calne SR.
    Transplantation; 2004 May 15; 77(9):1327. PubMed ID: 15167585
    [No Abstract] [Full Text] [Related]

  • 36. T-cell response against varicella-zoster virus in fingolimod-treated MS patients.
    Ricklin ME, Lorscheider J, Waschbisch A, Paroz C, Mehta SK, Pierson DL, Kuhle J, Fischer-Barnicol B, Sprenger T, Lindberg RL, Kappos L, Derfuss T.
    Neurology; 2013 Jul 09; 81(2):174-81. PubMed ID: 23700335
    [Abstract] [Full Text] [Related]

  • 37. Fingolimod for multiple sclerosis.
    Pelletier D, Hafler DA.
    N Engl J Med; 2012 Jan 26; 366(4):339-47. PubMed ID: 22276823
    [No Abstract] [Full Text] [Related]

  • 38. [Sphingosine-1-phosphate signaling system and the innovative mechanism of action of fingolimod in treatment of multiple sclerosis: review of foreign literature].
    Shmyrev VI, Kryzhanovskiĭ SM, Danilycheva IV.
    Zh Nevrol Psikhiatr Im S S Korsakova; 2012 Jan 26; 112(2 Pt 2):93-7. PubMed ID: 22677684
    [Abstract] [Full Text] [Related]

  • 39. Pearls & Oy-sters: an unusual case of varicella-zoster virus cerebellitis and vasculopathy.
    Calabria F, Zappini F, Vattemi G, Tinazzi M.
    Neurology; 2014 Jan 14; 82(2):e14-5. PubMed ID: 24419982
    [No Abstract] [Full Text] [Related]

  • 40. Ultrasmall superparamagnetic iron oxide-enhanced magnetic resonance imaging in experimental autoimmune encephalitis.
    Bendszus M, Stoll G.
    J Magn Reson Imaging; 2005 Jun 14; 21(6):850; author reply 850-1. PubMed ID: 15906328
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.